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Auto-inhibition of rat parallel ﬁbre–Purkinje cell synapses
by activity-dependent adenosine release
Mark J. Wall and Nicholas Dale
Neuroscience Group, Department of Biological Sciences, University of Warwick, Coventry, CV4 7AL, UK
Adenosine is an important signalling molecule involved in a large number of physiological
functions. In the brain these processes are as diverse as sleep, memory, locomotion and neuro-
protection during episodes of ischaemia and hypoxia. Although the actions of adenosine,
through cell surface G-protein-coupled receptors, are well characterized, in many cases the
sources of adenosine and mechanisms of release have not been deﬁned. Here we demonstrate
the activity-dependent release of adenosine in the cerebellum using a combination of electro-
physiology and biosensors. Short trains of electrical stimuli delivered to the molecular layer in
vitro,releaseadenosineviaaprocessthatisbothTTXandCa2+sensitive.AsATPreleasecannotbe
detected,adenosinemusteitherbereleaseddirectlyorrapidlyproducedbyhighlylocalizedand
efﬁcientextracellularATPbreakdown.Sinceadenosinereleasecanbemodulatedbyreceptorsthat
act on parallel ﬁbre–Purkinje cell synapses, we suggest that the parallel ﬁbres release adenosine.
This activity-dependent adenosine release exerts feedback inhibition of parallel ﬁbre–Purkinje
cell transmission. Spike-mediated adenosine release from parallel ﬁbres will thus powerfully
regulate cerebellar circuit output.
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Adenosine is an important neuromodulator in the central
nervous system, playing a role in a plethora of physio-
logical and pathophysiological processes. The action of
adenosine on cell surface receptors is well deﬁned with
A1,A 2a,A 2b and A3 receptors all cloned (Fredholm et al.
2000). Although extensively studied, the cellular source
and mechanisms of adenosine release remain unclear
(for review see Latini & Pedata, 2001). Adenosine can
in principle gain access to the extracellular space by
the breakdown of ATP, by translocation from cell cyto-
plasm via nucleoside transport proteins or possibly by the
exocytosisofadenosineitself.Therehasbeenconsiderable
investigation of adenosine release during pathological
episodes such as hypoxia, ischaemia and hypercapnia
as adenosine is neuroprotective (Rudolphi et al. 1992;
Fredholm, 1997; Dale et al. 2000; Dulla et al. 2005).
ReleaseundertheseconditionsisoftenCa2+ independent,
relatively insensitive to TTX and is not mediated via
glutamate receptor activation. In contrast, little is known
about the physiological release of adenosine with few
examples where a role and cellular source of adenosine
have been identiﬁed (but see Dale, 1998). In many cases,
adenosine release is evoked with stimuli such as high K+,
prolonged electrical stimulation and glutamate receptor
activation (Latini & Pedata, 2001). The physiological
relevance of these experiments is unclear.
The presence of adenosine, adenosine deaminase and
A1 receptors in the cerebellar cortex (Braas et al. 1986;
Geiger&Nagy,1986;Rivkeesetal.1995)stronglysuggests
that adenosine plays an important role in cerebellar
function. The activation of A1 receptors inhibits synaptic
transmission between parallel ﬁbres and Purkinje cells
(Kocsisetal.1984).Thesereceptorsaretonicallyactivated
byendogenousadenosine,sinceapplicationofA1 receptor
antagonists enhances synaptic transmission (Takahashi
et al. 1995; Dittman & Regehr, 1996). The source of this
adenosine has not been determined but could arise from
the release of adenosine or the release of ATP and its
subsequent metabolism. A recent report has suggested
that ATP can be released from parallel ﬁbres (Beierlein
& Regehr, 2006).
Toexaminethisissuewehaveusedselectiveandsensitive
microelectrodebiosensors(Llaudetetal.2003)tomeasure
the release of adenosine from cerebellar slices in real time.
These biosensors are small enough (25–50μm diameter)
to place either in or close to deﬁned areas in cerebellar
slices. Here we report that adenosine can be released from
themolecularlayerbyusingaphysiologicalstimulus,short
bursts(1–10s)offocalelectricalstimuliatthesamevoltage
usedtoelicitsynaptictransmission.Theadenosinerelease
isbothTTXandCa2+sensitiveanddoesnotappeartoarise
from the extracellular metabolism of ATP. Modulation
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of parallel ﬁbre–Purkinje cell synaptic transmission can
increaseordecreaseadenosinerelease,stronglysuggesting
that parallel ﬁbres are involved in adenosine release.
Methods
Slice preparation
Transverse slices of cerebellum (400μm) were prepared
from male Wistar rats, at postnatal days 21–28 (P21–28),
with modiﬁed methods based on Llinas & Sugimori
(1980). As previously described (Wall & Usowicz, 1997)
and in accordance with the UK Animals (Scientiﬁc
Procedures) Act 1986, male rats were killed by cervical
dislocation and decapitated. The cerebellum was rapidly
removed and transverse slices were cut on a Microm
HM650V microslicer (Carl Zeiss, Welwyn Garden City,
UK)incold(2–4◦C)highMg2+,lowCa 2+aCSF,composed
of (mm): 127 NaCl, 1.9 KCl, 7 MgCl2, 0.5 CaCl2, 1.2
KH2PO4,26NaHCO3,10d-glucose(pH7.4whenbubbled
with 95% O2 and 5% CO2). Slices were stored in normal
aCSF(1.3mmMgCl2,2.4mmCaCl2)atroomtemperature
for 1–6h before recording.
Recording from slices
An individual slice was transferred to a recording
chamber, submerged in aCSF and perfused at 6mlmin−1
(30–35◦C). The slice was placed upon a suspended
grid to allow perfusion of the slice from above and
below and thus reduce the likelihood of hypoxia. All
solutions were vigorously bubbled (95% O2 and 5%
CO2) and all tubing had low gas permeability (Tygon;
FisherScientiﬁc,Loughborough,UK).Forthestimulation
of purine release and parallel ﬁbre–Purkinje cell (PF)
EPSPs, square voltage pulses (2–8V, 200μs duration)
were delivered by an isolated pulse stimulator (Model
2100 AM systems; Olympic Peninsula, Washington, DC,
USA) via a concentric bipolar metal stimulating electrode
(FHC) placed on the surface of the molecular layer.
Purine biosensors were either positioned just above the
surface of the slice (bent so their longitudinal surface was
parallel to the stimulated molecular layer) or carefully
inserted (at an angle of ∼70deg) into the stimulated
molecular layer. For the extracellular recording of PF
EPSPs, an electrode (aCSF-ﬁlled microelectrode) was
placed on the same track along which the parallel ﬁbres
travel (for example see Yuan & Atchison, 1999). A
typical extracellular ﬁeld potential consisted of an initial
component which persisted in either 10μm CNQX or
5mm kynurenate but was blocked by 1μm TTX (parallel
ﬁbre volley), followed by a component which could be
block edby1μmTTXandgreatlyreducedbyeither10μm
CNQX or 5mm kynurenate. This component is probably
produced by parallel ﬁbre-mediated glutamatergic
excitatory synaptic currents and subsequent action
potentials in Purkinje cells and interneurones (Clark
& Barbour, 1997). Parallel ﬁbre EPSP amplitude was
estimatedfromtheCNQX/kynurenate-sensitivepotential,
which was measured by subtracting what remained in
CNQX/kynurenatefromcontrolpotentials.Conﬁrmation
ofPFEPSPidentitywasachievedbyevokingpairsofEPSPs
(interval 50ms) and observing facilitation (20–30%) and
by examining the pharmacological proﬁle (inhibition by
A1,GABAB andmGlu4Rreceptoragonists).Sensorsignals
were acquired at 1kHz with either a Digidata 1322A
(Axon) or a MiniDigi (Axon) using pCLAMP 9.2 (Axon)
or Axoscope 9.2 (Axon). Extracellular recordings were
made using an ISO-DAM extracellular ampliﬁer (WPI,
Stevenage, UK), ﬁltered at 1kHz and digitized on line
(10kHz) with a Digidata 1322A controlled by pCLAMP
9.2.
Biosensor characteristics
Biosensors were obtained from Sarissa Biomedical Ltd
(Coventry,UK).Inbrieftheadenosinebiosensorconsisted
of three entrapped enzymes (adenosine deaminase,
nucleoside phosphorylase and xanthine oxidase) within
a matrix that was deposited around a Pt or Pt/Ir (90/10)
wire etched to 25–50μm (Llaudet et al. 2003). The
biosensor had an exposed length of 500μm that was
coatedwithenzymesandthuscapableofdetectingpurines.
Biosensorshadanadditionalscreeninglayer,whichgreatly
reduced the responses to non-speciﬁc electro active inter-
ferents (such as 5-HT, dopamine, noradrenaline and
ascorbate). Screened null sensors, possessing the matrix
but no enzymes, were used to control for the release
of any non-speciﬁc electro active interferents. The ATP
biosensor consisted of the entrapped enzymes glycerol
kinase and glycerol-3-phosphate oxidase (Llaudet et al.
2005). Glycerol (2mm) was included in solutions as
glycerol is a co-substrate required for ATP detection.
Biosensors were calibrated with known concentrations
of adenosine and ATP (10μm typically giving responses
of 2–3nA for adenosine and 1.5nA for ATP). Calibration
wasperformedbeforetheslicewaspresentintheperfusion
chamber and after the experiment (following slice
removal),thisallowingquantiﬁcationofanyrun-downin
sensitivity during the experiment. Previous reports have
detailed the properties of adenosine and ATP biosensors
(Llaudet et al. 2003, 2005): selectivity, linear responses to
increasing analyte concentration and rapid response.
Determination of ATP breakdown inhibition
Todeterminewhichcompoundswerethemosteffectiveat
blocking the extracellular metabolism of ATP, the break-
down of etheno-ATP (ε-ATP) was measured using HPLC.
Individual 400μm cerebellar slices were incubated (on a
shaker,atroomtemperature)in400μlofaCSFcontaining
either 5 or 50μm ε-ATP (2 or 20nmol of ε-ATP) with or
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without inhibitors. At 0, 10, 25 and 45min, 50μl samples
were taken and snap frozen with dry ice.
Samples were thawed out and diluted (1 in 10) in
distilled water. HPLC analysis was performed with a Luna
C8 (2) reverse phase column and a Thermo Separation
Products HPLC gradient pump (P2000) and ﬂuorescence
detector (FL3000). The mobile phase consisted of 20mm
potassium phosphate pH6.0 (solution A) and 75%
potassiumphosphatepH6.0and25%methanol(solution
B). A concave gradient was run going from 100%
solution A to 100% solution B in 10min. ε-ATP typically
eluted around 3.5min, ε-ADP around 4min, ε-AMP
5min and ε-adenosine around 9min. The column was
re-equilibrated with solution A for 10min between runs.
To quantify ε-ATP breakdown, the relative proportions of
the breakdown products was obtained from peak areas.
Drugs
All drugs were made up as 10–100mm stock solutions,
stored frozen and then thawed and diluted with aCSF on
the day of use. R(+)-baclofen hydrochloride, muscimol
Evans Blue, α,β-methylene-ADP, adenosine, inosine, 6-[
(4-nitrobenzyl)thiol]-9-β-d-ribofuranosylpurine(NBTI)
8-cyclopentyltheophylline (8CPT) and dipyridamole
were purchased from Sigma. Erythro-9-(2-hydroxy-
3-nonyl) adenine (EHNA), 6-cyano-7-nitroquinoxaline-
2,3-dione (CNQX), ARL67165, l-AP4, d(–)-2-
amino-5-phosphonopentanoic acid (AP5) were
purchased from Tocris-Cookson. ATP was purchased
from Roche and etheno-ATP (ε-ATP) was purchased as a
5mm solution from Invitrogen.
Results
Trains of electrical stimuli release adenosine in the
molecular layer
To investigate the release of purines in the cerebellum,
trains (1–10s, 2–20Hz) of electrical stimuli were applied
to areas of the cerebellum and purine release measured
in real time using speciﬁc and selective microelectrode
biosensors (Llaudet et al. 2003). Stimuli applied to
the molecular layer of transverse slices, consistently
produced a slow rising current on adenosine biosensors,
positioned on the surface of the molecular layer (Fig.1A).
Movement of the stimulator and sensor to the adjacent
granule cell layer caused a loss of current, suggesting the
detected analyte was released in the molecular layer. The
sensor-current (amplitude 20–200pA) had a 10–90% rise
time of 14.4±2.2s and a 10–90% decay of 131.6±14.2s
(n=30). The current was due to purine detection, as no
current was produced on a null sensor (identical to an
adenosinesensorbutlackingthepurinedetectionenzyme
cascade) placed close to the adenosine biosensor (n=8,
Fig.1A). The current waveform was not determined by
sensor-response kinetics, as it was much slower than
the sensor response to purine application (Llaudet et al.
2003). Since the adenosine biosensors can detect inosine
and hypoxanthine as well as adenosine, EHNA, a speciﬁc
inhibitor of adenosine deaminase (the ﬁrst enzyme in the
biosensor enzyme cascade), was used to determine the
purinedetected(Agarwaletal.1977;Saﬁulinaetal.2005).
EHNA (20μm) greatly reduced (85±5%, n=3) the
response of adenosine biosensors to exogenous adenosine
(10μm) but had no effect on the detection of inosine
(and by inference hypoxanthine, Fig.1B). In ﬁve slices,
applicationof20μmEHNAgreatlyreducedthebiosensor
current following stimulation (mean inhibition 75±3%,
Fig.1C). Thus, most of the biosensor current results from
adenosine detection. The remaining current is probably a
combination of adenosine (as EHNA only partial blocks
the adenosine sensor response) and inosine either directly
releasedorasaconsequenceofadenosinebreakdown(due
to incomplete inhibition of adenosine deaminase in the
slice).
The amount of adenosine released was dependent on
both the frequency and duration of stimulation. With
100 stimuli, no adenosine release could be detected
Figure 1. Electrical stimulation in the molecular layer releases
adenosine
A, superimposed current traces from adenosine (Ado) and null
biosensors following electrical stimulation of the molecular layer (5 V
for 5 s at arrow). The lack of signal on the null sensor indicates that
the current on the adenosine biosensor is due to purine detection and
is not non-speciﬁc. B, application of 10 μM adenosine (Ado) and then
10 μM inosine (Ino) produced current responses on an adenosine
biosensor. Addition of 20 μM EHNA (to block adenosine deaminase)
almost abolished the response to adenosine but had little effect on the
response to inosine. C, superimposed traces from an adenosine
biosensor in control and in the presence of 20 μM EHNA (to block
adenosine deaminase) following electrical stimulation of the molecular
layer (8 V for 8 s at arrow). EHNA reduced the current by ∼75%
demonstrating that most of the signal is due to adenosine detection.
All stimulations were at a frequency of 20 Hz.
C   2007 The Authors. Journal compilation C   2007 The Physiological Society556 M. J. Wall and N. Dale J Physiol 581.2
at a frequency of 2Hz but was detected at 5Hz.
Maximal adenosine release occurred around 20Hz with
little increase at higher frequencies (40–80Hz, Fig.2A).
Increasing the stimulus train length released more
adenosine (Fig.2B). At 20Hz, the shortest train to release
detectable adenosine was ∼1s (20 stimuli) but in most
slices 5–8s (100–160 stimuli) were required. With an
interval between trains of stimuli of 5min, adenosine
release was reliable and did not decrement. However,
with shorter intervals the amount of adenosine released
diminished. If it is assumed that all the sensor-current
results from adenosine detection, then it is possible to
calculate the adenosine concentration at the sensor. In 15
slices,an8s(20Hz)stimulationproducedconcentrations
ranging from 130 to 1650nm (mean 492±89nm). This
rangeofconcentrationsmaystemfromdifferentdistances
between the adenosine release sites and the biosensor.
Mechanisms of adenosine release
We next examined the TTX-, Ca2+-and receptor-
sensitivityofadenosinerelease.Applicationofthesodium
channel blocker TTX (0.5–1μm) abolished adenosine
Figure 2. Properties of adenosine release
A, graph summarizing how adenosine release varies with stimulation
frequency (data from 4 slices). The number of stimuli was kept
constant (100) and the stimulation frequency was varied between 2
and 80 Hz. The data are normalized to the concentration of adenosine
detected at a stimulus frequency of 20 Hz. B, superimposed traces
from an adenosine biosensor following 20, 100 and 160 stimuli. The
stimulus frequency was kept constant at 20 Hz. The stimulation
strength was between 3 and 8 V (A) and 5 V (B).
release (n=11, Fig.3A) demonstrating that adenosine
release is action potential dependent. In seven slices,
adenosine release was also abolished by substitution of
normal aCSF for Ca2+-free aCSF (Mg2+ increased to
3.7mm, Fig.3B). To measure the Ca2+ dependence of
Figure 3. Mechanisms of adenosine release
A, superimposed current traces from an adenosine biosensor placed on
the surface of the molecular layer in control, in 10 μM CNQX + 50 μM
AP5 and in 0.5 μM TTX. The adenosine release following electrical
stimulation (5 V, 8 s at arrow) was abolished by TTX but was insensitive
to the block of glutamate receptors. B, superimposed traces from an
adenosine biosensor placed on the surface of the molecular layer in
control, Ca2+-free aCSF (3.7 mM Mg2+) and following reintroduction
of Ca2+ (wash). The adenosine release following electrical stimulation
(7 V, 8 s at arrow) was abolished by removal of Ca2+. Inset, graph
plotting normalized adenosine release against external Ca2+
concentration. Adenosine release was normalized to what occurred at
2.4 mM Ca2+ and summarizes data from 6 slices. C, superimposed
traces from an adenosine biosensor placed on the surface of the
molecular layer in control and in the presence of the GABAA receptor
agonist muscimol (30 μM). Adenosine was released by a 5 V, 7 s
stimulus at the arrow. Inset, superimposed averages of EPSPs in
control and in 30 μM muscimol (∗). Muscimol reduced EPSP amplitude
but had little effect on the volley. D, superimposed traces from an
adenosine biosensor placed on the surface of the molecular layer in
control and in the presence of 5 μM NBTI and 10 μM dipyridamole to
block equilibrative transport. Adenosine was released by a 5 V, 7 s
stimulus at the arrow. All stimuli were at a frequency of 20 Hz.
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adenosine release, extracellular Ca2+ concentration was
changed between 0.5 and 5mm with Mg2+ kept at
1.3mm. Adenosine release was examined in the presence
of 1μm 8CPT to block A1 receptors (see later). The Ca2+
dependence was approximately linear (1.1±0.1, n=6,
Fig.3B inset) which is lower than that measured for
classical neurotransmitters (Dodge & Rahamimoff, 1967;
Mintz et al. 1995; Reid et al. 1998).
It is possible that the action potential-dependent
opening of Ca2+ channels and subsequent entry of Ca2+
directly causes the release of adenosine. However, it is also
possible that the stimulation indirectly evokes adenosine
releasethroughthedownstreamactionsofanotherneuro-
transmitter. We have taken two approaches to address this
possibility. Firstly, we have tested the most likely neuro-
transmittercandidatesthatcouldperformthisrole(mean
current in control versus mean current with antagonist
present). Adenosine release was not sensitive to 10μm
CNQX and 50μm AP5 (AMPA and NMDA glutamate
receptorantagonists,53.5±10versus51.8±11pA,n=5,
Fig.3A), 100μm CPCCOET or 300μm AIDA (Group1
mGluRantagonists,44.2±13versus52±18.5pA,n=3),
10μm PPADs (P2 receptor antagonist, 34.6±5 versus
32.8±4.3pA, n=3), 300μml -NMMA (NO synthase
inhibitor, n=4, 25.3±6.3 versus 21.6±5pA) and
prazosin (α1 adrenoceptor antagonist, 103±13 versus
99.6±14pA, n=3). Furthermore application of 10μm
5-HT or 10μm noradrenaline did not induce adenosine
release (n=3). Secondly, we have applied the GABAA
receptor agonist muscimol (30μm) and measured
adenosine release. The rationale for this approach is that
the activation of GABAA receptors will hyperpolarize and
reduce the input resistance of neurones. The actions of
muscimol on glia are less certain, but Bergmann glia
express GABAA receptors on their processes and therefore
maybeinhibited(Riquelmeetal.2002).Thus,ifadenosine
is released as a consequence of the downstream actions of
another transmitter, inhibition of the target cells should
greatly reduce or abolish adenosine release. Furthermore,
if GABAA receptors are not present on parallel ﬁbres
and parallel ﬁbres are the source of adenosine then
muscimol should have no effect on adenosine release.
The effectiveness of muscimol (30μm) was conﬁrmed by
two observations: (1) the prolonged loss of spontaneous
actionpotentialﬁringinPurkinjecellsfollowingmuscimol
application (n=3) and (2) muscimol (30μm) reduced
theamplitudeofparallelﬁbreEPSPsby56±6.2%(n=6)
with little effect upon the parallel ﬁbre volley (8.1±7.7%
reduction, Fig.3C inset, n=6). The lack of effect of
muscimol on the parallel ﬁbre volley suggests few GABAA
receptors are expressed by parallel ﬁbres and thus the
reduction in EPSP amplitude results from a reduction in
the resistance of Purkinje cells. Since muscimol (30μm)
had no signiﬁcant effect on the magnitude of adenosine
release (55.3±8.5 versus 58.1±8.1pA, Fig.3C, n=5)
it seems very unlikely that adenosine is released as a
result of the downstream actions of another transmitter.
Furthermore it is unlikely to come from Purkinje cells or
interneurones as they will be shunted by GABAA receptor
activation.
Direct release of adenosine could occur via the
equilibrative nucleoside transporters ENT1 and ENT2
translocating adenosine from the cytoplasm to the
extracellular space. However, blockade of these molecules
by a combination of 5μm NBTI and 10μm dipyridamole
(for review see Noji et al. 2004) had no signiﬁcant
(P =0.71) effect on the amount of adenosine released
(n=5, Fig.3D, 41.6±7.8 versus 38.3±10.7pA, 1μm
8CPT was present to prevent A1 receptor activation).
Adenosinewasnotreleasedasaresultofelectroporation
and consequent release of cytoplasmic ATP (for example,
seeHamann&Attwell,1996)(withsubsequentconversion
to adenosine by ecto-ATPases) since electroporation is
insensitive to TTX and only occurred at much higher
stimulus strengths (see later and Fig.4C).
ATP release cannot be detected
An important potential source of adenosine is the
extracellular metabolism of ATP. To investigate whether
adenosine is released in the form of ATP, a number of
approaches were taken. Firstly, ATP biosensors were used
to test directly for ATP release (Llaudet et al. 2005). These
biosensors have a detection limit of ∼60nm (producing
∼10pA of current). In eight slices an ATP biosensor
was positioned close to the adenosine biosensor on the
surface of the molecular layer. Following stimulation,
adenosine was detected but no signal was observed on
the ATP biosensor. In three further slices, after measuring
adenosine release, the adenosine biosensor was carefully
removed and replaced with an ATP sensor (thus potential
ATP release was measured in exactly the same place
where adenosine was detected). Again there was no signal
following stimulation. It is possible that ATP is released
deepwithinthesliceandisthenmetabolizedtoadenosine
before it reaches the sensor on the surface of the slice.
To investigate this, ATP biosensors were inserted into
the molecular layer, in the region where adenosine was
detected. Again no signal was observed on the ATP
sensor following stimulation, although adenosine could
still be detected on the slice surface (n=8, Fig.4A). To
reduce the possible extracellular ATP breakdown we have
made use of three agents: Evans Blue and ARL67156
(which inhibit ecto-ATPases, Crack et al. 1995; Bultmann
et al. 1999) and α,β-methylene-ADP (which inhibits
ecto-5 -nucleotidase,forreviewseeZimmerman,1996).In
the presence of Evans Blue (100μm, n=5) or ARL67156
(100μm, n=3) no signal was detected on the inserted
ATP sensor and the adenosine signal was not signiﬁcantly
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different from the control (P =0.53, Fig.4B). There was
also no signiﬁcant difference between the amount of
adenosine detected in control, following application of
100μm α,β-methylene-ADP (47±19 versus 54±17pA,
P =0.06) and after wash (P =0.22).
We have exploited the electroporation-induced release
of ATP (Hamann & Attwell, 1996) to measure the kinetics
ofATPbreakdown.AnATPbiosensorwasinsertedintothe
molecular layer and an adenosine sensor was placed very
close to the ATP sensor on the surface of the molecular
layer. TTX (0.5μm) was present to prevent TTX-sensitive
adenosine release. Following 30–35V stimulation, ATP
wasreleasedandtheresultantbreakdowntoadenosinewas
measured by the adenosine biosensor (Fig.4C). Although
ATP breakdown was rapid, only 15±5% of the ATP
Figure 4. ATP release is not detected
A, superimposed traces from an adenosine biosensor placed on the
surface of the molecular layer and an ATP biosensor placed within the
molecular layer. To maximize the likelihood of detecting ATP,
adenosine was ﬁrst detected (by an adenosine biosensor) then the ATP
biosensor was placed in the molecular layer where the adenosine was
detected. Following stimulation (arrow, 10 s) although adenosine was
detected, no ATP release was measured. B, superimposed traces from
an adenosine biosensor placed on the surface of the molecular layer
and an ATP biosensor placed within the molecular layer. Following the
application of the ecto-ATPase inhibitor Evans Blue (100 μM) the
adenosine current was not diminished and there was still no ATP
detection. The traces in B are from the same slice as in A. C,
superimposed traces from an adenosine biosensor placed on the
surface of the molecular layer and an ATP biosensor placed within the
layer as in A and B. The biosensors were positioned at an
approximately equal distance from the stimulating electrode. TTX
(0.5 μM) was present to block TTX-dependent adenosine release.
Stimulation (30 V, 10 s) caused cell damage and resulted in the
electroporation of ATP, which produced a large current on the ATP
biosensor. A small proportion of the released ATP (∼20%) was broken
down to adenosine and was detected by the adenosine biosensor. The
traces in C have been scaled by sensor calibration. All stimulations
were at 20 Hz.
was converted to adenosine (n=4). If adenosine were to
arise from ATP breakdown, this suggests that to give the
observed signal of ∼0.5μm adenosine, around 2.5–5μm
ATP would have to be released. This quantity of ATP
would give an easily measurable signal on the ATP sensor.
Therefore it seems unlikely that adenosine arises from the
extracellular breakdown of ATP.
Inhibitors slow ATP metabolism
The inability to either directly detect ATP or reduce the
adenosine signal could reﬂect an inability to block the
ecto-ATPases and 5 -nucleotidases which convert ATP
to adenosine. Thus, we have assayed the effectiveness
of Evans Blue, ARL67156 and α,β-methylene-ADP
in preventing either ATP breakdown or conversion of
ATP to adenosine using HPLC (Fig. 5). We added
ε-ATP (5 and 50μm) to cerebellar slices and observed
the metabolism and resultant build up of ε-adenosine
(Fig.5A and D). Although the ecto-ATPase inhibitors
ARL67156 and Evans Blue (100μm) did not abolish
ε-ATP breakdown they did slow its rate of metabolism
(Fig.5B and C). At both 5 and 50μm ε-ATP, Evans
Blue was a more effective inhibitor than ARL67156.
For example, after 25min only 8.6% of 5μm ε-ATP
remained in control, compared with 39.3% in Evans Blue
and 26.4% in ARL67156. Both inhibitors appeared more
effective at lower substrate concentrations, suggesting a
competitivemodeofaction.Otherecto-ATPaseinhibitors,
such as α,β-methylene-ADP, suramin and PPADs, were
less effective than Evans Blue (not illustrated).
Although the ecto-5 -nucelotidase inhibitor,
α,β-methylene-ADP (100μm), had little effect on ATP
breakdown, it was the most effective in slowing adenosine
formation(Fig.5C andF).α,β-Methylene-ADP(100μm)
appeared to slow conversion to adenosine by reducing the
breakdown of ADP and reducing the conversion of AMP
to adenosine. Again, inhibition of adenosine formation
was more effective at lower substrate concentrations.
These enzyme inhibitors would be expected to slow
(but not block) the breakdown of ATP/formation of
adenosine,withtheireffectivenessdependentonsubstrate
concentration. As they had no effect on the adenosine
signal and did not reveal an ATP signal, we conclude that
ATP breakdown is most unlikely to contribute to the
observed adenosine release.
Adenosine release can be decreased by inhibiting
parallel ﬁbre transmission
Our data suggest that the most likely source of adenosine
is the parallel ﬁbres (granule cell axons) which run
along the molecular layer making glutamatergic synapses
onto Purkinje cells. These parallel ﬁbre–Purkinje cell
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synapses are inhibited by presynaptic GABAB and mGlu4
receptors (Batchelor & Garthwaite, 1992; Neale et al.
2001). If adenosine is released from parallel ﬁbres (or
parallel ﬁbres release a transmitter required for adenosine
Figure 5. Metabolism of ε-ATP by cerebellar slices at room temperature
A, graph plotting percentage composition against time for the breakdown of 50 μM ε-ATP. At time zero there was
∼90% ATP () and 10% ADP (). Following incubation there was a fall in the proportion of ATP and a subsequent
increase in AMP () and adenosine ( ) with little change in ADP. B, graph plotting percentage of 50 μM ε-ATP
remaining against time in control and in the presence of inhibitors (Evans Blue and ARL67156). C, graph plotting
percentage of adenosine against time in control and in the presence of inhibitors during metabolism of 50 μM
ε-ATP. α,β-Methylene-ADP (100 μM) was the most effective in slowing the build-up of adenosine. D, graph plotting
percentage composition against time for the breakdown of 5 μM ε-ATP. There was a more rapid breakdown of
5 μM ATP compared with 50 μM ε-ATP (compare with A). E, graph plotting percentage of ε-ATP (5 μM) remaining
against time in control and in the presence of inhibitors. Note that both Evans Blue and ARL67156 (100 μM)
were more effective at slowing the metabolism of 5 μM versus 50 μM ε-ATP (compare E and B). F, graph plotting
percentage of adenosine against time in control and in the presence of inhibitors during metabolism of 5 μM
ε-ATP. Again inhibitors are more effective at slowing build up of adenosine with lower concentrations of substrate.
Graphs A, B and C summarize data from 4 experiments; graphs D, E and F are from 3 experiments.
release) then adenosine release should also be modulated
by these presynaptic receptors. Thus, adenosine release
was measured before and after the addition of the
GABAB receptor agonist baclofen (10–50μm). Baclofen
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Figure 6. Adenosine release is modulated by parallel ﬁbre
receptor agonists
Parallel ﬁbre (PF) EPSPs were evoked every 10 s by a stimulating
electrode placed on the surface of the molecular layer and recorded
with an extracellular electrode. A, superimposed averages of EPSPs in
control, in 25 μM baclofen and following wash. Baclofen reversibly
reduced EPSP amplitude by ∼60%. B, superimposed traces from an
adenosine biosensor in control, baclofen (25 μM) and in wash.
Adenosine release was evoked by a 10 s stimulus at the arrow.
Baclofen reversibly reduced adenosine release by ∼50%. C,
superimposed averages of EPSPs in control, in 50 μML -AP4 and
following wash. L-AP4 reversibly reduced EPSP amplitude by ∼40%.
D, superimposed traces from an adenosine biosensor placed on the
surface of the molecular layer in control, 50 μML -AP4 and in wash.
Following L-AP4 application adenosine release was decreased by
∼40%. Adenosine release was evoked by a 5 s stimulus (20 Hz) at the
arrow.
reversibly reduced parallel ﬁbre (PF) EPSP amplitude
by 67.8±4.9% (n=6, Fig.6A) and also signiﬁcantly
reduced adenosine release by 66.5±8% (n=5, Fig.6B).
Parallel ﬁbres are also modulated by mGluR4 receptors:
applicationofthemGluR4receptoragonistl-AP4(50μm)
caused a reversible decrease in PF EPSP amplitude
(41.3±8%,n=4,Fig.6C).Applicationofl-AP4(50μm)
caused a signiﬁcant (P <0.05) reversible decrease in
the amplitude of adenosine signals (44.2%, 60±17.7
versus 33.5±10.6pA, n=4, Fig.6D) demonstrating that
adenosinereleaseisalsomodulatedbymGluR4receptors.
The matching of the pharmacological proﬁle of parallel
ﬁbre–Purkinje cell synaptic transmission with that of
adenosine release strongly suggests that activation of
parallel ﬁbres is essential for the activity-dependent
adenosine release and this release can be modulated by
endogenous transmitters.
Endogenous adenosine release modulates
information ﬂow in the cerebellum
Parallel ﬁbre to Purkinje cell synaptic transmission is
inhibited by presynaptic A1 receptors (Kocsis et al.
1984; Rivkees et al. 1995) which raises two possibilities:
ﬁrstly adenosine release from parallel ﬁbres should be
modulated by endogenous adenosine and secondly, the
released adenosine could inhibit parallel ﬁbre–Purkinje
cell synaptic transmission and inhibit adenosine release
(negative feedback). To test the ﬁrst possibility, the effects
of an A1 receptor antagonist on adenosine release were
investigated. Block of A1 receptors (8CPT, 1μm) caused
an increase in PF EPSP amplitude (45.8±10%, n=10,
Fig.7A) demonstrating continual adenosine-mediated
inhibition and the presence of an extracellular adenosine
tone (Takahashi et al. 1995; Dittman & Regehr, 1996).
Application of 8CPT (1μm) also caused a signiﬁcant
increase in the amplitude of adenosine signals (89±15%,
n=8,Fig.7B)demonstratingthatadenosinereleaseisalso
modulated by the level of extracellular adenosine. The
muchlargereffectof8CPTonadenosinereleasecompared
with PF EPSPs may stem from the block of adenosine
auto-inhibition (released adenosine binds to A1 receptors
andinhibitsitsownrelease).Weinvestigatedthefeasibility
of this by examining modulation of parallel ﬁbre trans-
mitter release by released adenosine. If the concentration
of adenosine released reaches a sufﬁcient magnitude, it
should inhibit glutamate release from parallel ﬁbres (via
the activation of A1 receptors). PF EPSPs were evoked
every 10s (to measure baseline transmission) and then
a 10s train (20Hz) of stimuli was delivered to release
adenosine.Followingthetrainofstimuli,theamplitudeof
PF EPSPs was diminished but then slowly recovered back
to the baseline (mean recovery time 122±6.5s, n=6)
with a time course very similar to the decay of adenosine
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release(decay∼130s,Fig.7C andD).Applicationof1μm
8 CPT, to block the A1 receptors, signiﬁcantly increased
the speed of recovery following the train (recovery time
reducedfrom122±6.5to44±8.7s,Fig.7CandD).Thus,
parallel ﬁbre-dependent adenosine release is functionally
important and acts to auto inhibit both the parallel
ﬁbre–Purkinje cell synapse and indeed adenosine release
itself.
Discussion
We have demonstrated that adenosine can be released
from the molecular layer of cerebellar slices by electrical
stimulation. This release of adenosine was via a process
that is both TTX and Ca2+ sensitive and as ATP release
cannot be detected, adenosine is either released directly
or rapidly produced by efﬁcient extracellular ATP break-
down.Sinceadenosinereleasewasmodulatedbyreceptors
that act on parallel ﬁbre–Purkinje cell synapses, parallel
ﬁbresarethemostlikelysourceofadenosine.Noprevious
study has measured adenosine release from cerebellar
slices, although adenosine can be released from cultured
granule cells (Schousboe et al. 1989; Philibert & Dutton,
1989; Sweeney, 1996). Prolonged electrical stimulation
(1–5min) can release adenosine in other brain regions
(thecortex,hippocampusandstriatum,Pedataetal.1990;
Lloyd et al. 1993). However, we have characterized the
properties of adenosine release evoked by a plausibly
Figure 7. The adenosine released by electrical
stimulation modulates parallel ﬁbre–Purkinje cell
synaptic transmission
Parallel ﬁbre (PF) EPSPs were evoked every 10 s by a
stimulating electrode placed on the surface of the
molecular layer and recorded with an extracellular
electrode. A, graph plotting PF EPSP amplitude against
time. Application of 1 μM 8CPT, to block A1 receptors,
increased EPSP amplitude by ∼30%. B, superimposed
traces from an adenosine biosensor in control and in the
presence of 1 μM 8CPT. Adenosine release was evoked
by a 7 s stimulus at the arrow. Application of 8CPT
increased adenosine release by 43%. C, graph plotting
PF EPSP (evoked every 10 s) amplitude against time. At
the asterisk a train of stimuli was delivered (10 s, 20 Hz)
to cause adenosine release. Following the train there
was a marked reduction in PF EPSP amplitude followed
by a slow recovery back to control amplitude (PF EPSP
amplitude during the train is not plotted). The time
course of PF EPSP amplitude recovery was ∼150 s which
is very similar to the time course of adenosine release.
Application of the A1 receptor antagonist 8CPT
increased PF EPSP amplitude by ∼25% and also
markedly speeded recovery following a train of stimuli
(∼50 s). Thus, the slow component of recovery results
from the released adenosine activating A1 receptors. D,
graph summarizing data from 6 recordings. Following
blockade of A1 receptors there was signiﬁcant speeding
of EPSP recovery.
physiological stimulus: short duration trains (1–10s),
localizedtoasmallareaofthesliceandatthesameminimal
strength that evokes transmitter release.
What is the source of adenosine?
We have provided strong evidence that parallel ﬁbre
activity is required for adenosine release. Firstly, the
stimulating electrode and biosensors were arranged along
a beam of parallel ﬁbres; thus, parallel ﬁbres are activated
by the stimulus and the sensors are in the correct place to
measurewhatisreleased.Secondly,activationorinhibition
of the G-protein coupled receptors (GABAB,A 1 and
mGluR4) present on parallel ﬁbre terminals modulates
adenosine release by a similar magnitude as synaptic
transmission. This proportionality in the reduction of
EPSPamplitudeandadenosinereleasesuggestsacommon
mechanismforadenosineandglutamaterelease.However,
there are apparent differences. Our results suggest that
the dependence of adenosine release on extracellular
Ca2+ is ∼1 whereas previous studies have shown that
the Ca2+ dependence of glutamate release at parallel
ﬁbre synapses is ∼3 (Mintz et al. 1995; Brown et al.
2004). This difference in Ca2+ dependence may be more
apparent than real as different stimuli were used to elicit
glutamate and adenosine release. Single stimuli were used
to evoke glutamate release (Mintz et al. 1995; Brown
et al. 2004) whereas in this study, trains of stimuli were
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required to release adenosine. The Ca2+ dynamics during
a train of stimuli will be more complex than for a single
stimulusandmayresultinintracellularCa2+accumulation
thus reducing the apparent dependence on extracellular
Ca2+. Thirdly, it is physiologically plausible that parallel
ﬁbres maintain transmitter release at frequencies up to
and above the stimulation frequency used in this study
(Kreitzer & Regehr, 2000). Thus, parallel ﬁbre-dependent
adenosine release could occur physiologically and act to
limit parallel ﬁbre-dependent excitation of Purkinje cells.
Finally,movingthebiosensorfurtheraway(alongthesame
beam of parallel ﬁbres) resulted in only a small reduction
in current amplitude with little change in rise time.
Other possible sources of adenosine include Purkinje
cells,interneuronesandglia.Stimulationinthemolecular
layerwillactivateallthesecelltypesbuttheTTXsensitivity
of adenosine release makes Bergmann glia an unlikely
source of adenosine as they do not ﬁre action potentials
(Clark & Barbour, 1997). Purkinje cells are strongly
immunoreactive for adenosine (Braas et al. 1986) and
express GABAB receptors in their dendrites (Lujan &
Shigemoto, 2006) but there is little evidence that Purkinje
cells express either A1 adenosine receptors or mGluR4
receptors. The restricted expression of mGluR4 receptors
also means adenosine release from molecular layer inter-
neurones is unlikely (Mateos et al. 1998). We can also
exclude glutamate released from parallel ﬁbres activating
receptorsonneuronesandglia,sinceadenosinereleasewas
not blocked by the glutamate receptor antagonists CNQX
and AP5. Furthermore Purkinje cells, interneurones and
(possibly) Bergmann glia will be shunted by application
of the GABAA receptor agonist muscimol, which had no
effect on adenosine release. Thus, the most likely source
of adenosine is the parallel ﬁbres. However, on several
occasions it has been possible to stimulate parallel ﬁbres
and record EPSPs without observing release of detectable
amounts of adenosine. Thus, perhaps only a subset of
parallel ﬁbres release adenosine.
Properties of adenosine release
Some of the characteristics of adenosine release appear
different from parallel ﬁbre–Purkinje cell synaptic trans-
mission. Firstly, a single stimulus is sufﬁcient to evoke
glutamate release from parallel ﬁbres, yet a train of such
stimuli is required to produce an adenosine signal on the
biosensor.Thiscouldsimplyreﬂectthatenoughadenosine
hastobereleasedtodiffusethroughthetissuetoreachthe
sensor on the slice surface. Clearly the distance between
synaptic glutamate receptors and the release sites is much
smaller than that between the adenosine biosensor and
release sites. Thus, the requirement for trains of stimuli
could be an artefact of the recording system. However,
similar stimulation protocols were required when the
sensorswerepushedintothemolecularlayer(presumably
the sensor will be closer to the release sites). At the calyx
ofHeld,trainsofstimuli(10Hz)releaseadenosine,which
can be detected indirectly through the activation of A1
receptors and the consequent inhibition of transmitter
release. This inhibition only reaches signiﬁcance after
the ﬁrst 20 stimuli in a train, suggesting that multiple
stimuli are required to release adenosine (Kimura et al.
2003; Wong et al. 2006). In the hippocampus, 10Hz but
not 3Hz stimulation released adenosine (measured by
inhibitionofEPSCs,Brager&Thompson,2003).Secondly,
once released the time course of adenosine was very
slow. The decay of adenosine takes around 130s which
is vastly longer than that for classical fast transmitters
like glutamate. This is similar to neuropeptides, which
have a long duration of action and act in a paracrine
manneraffectingmanyneurones.Thismayreﬂectthelarge
number of parallel ﬁbres that are stimulated resulting in
thespilloverofadenosineanddiffusionoveralargearea.
Mechanism of adenosine release?
The inhibition of ENT1 and ENT2 had no effect on
adenosinereleaseandthusadenosinewasnottransported
across the cell membrane by these equilibrative trans-
porters. NBTI and dipyridamole do inhibit adenosine
transport leading to greater synaptic inhibition in the
cerebellum (M. J. Wall, personal observation) and in
the hippocampus (Frenguelli et al. 2007). However, it
is possible that other transporters, which are insensitive
to NBTI/dipyridamole, are involved in adenosine release.
Adenosine release was blocked by TTX and by removal of
Ca2+. The calcium dependence of adenosine release was
lower than that reported for classical neurotransmitters,
but was similar to that reported for the release of neuro-
peptides (for example see Peng & Zucker, 1993). The
adenosine release thus has the characteristics associated
with conventional synaptic release. Nevertheless there are
threealternateinterpretationsofourdata.Firstly,aninter-
mediate transmitter could in principle cause the down-
streamreleaseofadenosine.Thisseemsunlikelyaswehave
eliminatedtheobviouscandidatesforsuchanintermediate
transmitter and have shown that inhibiting neurones and
glia (through GABAA receptor activation) has little effect
onadenosinerelease.Secondly,actionpotentialactivityin
parallel ﬁbres could release potassium which depolarizes
other cells (including glia) resulting in adenosine release.
Thisseemsunlikelyasactivationofparallelﬁbrereceptors
(GABAB,A 1 and mGlu4R) inhibits adenosine release but
wouldnotaffecttheamountofpotassiumreleasedduring
actionpotentials.Furthermoreanycellsdepolarizedbythe
potassium efﬂux would probably be shunted by GABAA
receptor activation suggesting that this treatment should
diminish release if that were the case.
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Thirdly, adenosine could arise from the breakdown of
exocytotically released ATP. Beierlein & Regehr (2006)
have recently described parallel ﬁbre-mediated Ca2+ rises
in Bergmann glia that are blocked by PPADs (50μm)
and may thus depend on parallel ﬁbre-mediated ATP
release.However,wehavebeenunabletomeasureanyATP
release (either with or without ecto-ATPase inhibition).
Thus, the ATP released from parallel ﬁbres, as reported
by Beierlein & Regehr (2006), may be too small to detect
by our methods. This contrasts with studies in the retina
where glial cells release ATP which is rapidly converted
by ectoenzymes into adenosine. In this case, the ATP can
be detected using luciferin–luciferase chemiluminescence
and blockers of ATP breakdown reduce the production
of adenosine (reviewed by Newman, 2004). In the
hippocampus, it has been reported that exogenous ATP is
converted to adenosine in less than a second (Dunwiddie
et al. 1997). More recent experiments demonstrated that
only a small proportion (∼7%) of bath-applied ATP is
converted, albeit rapidly to adenosine by hippocampal
slices(Frenguellietal.2007).Ourexperimentssuggestthat
inthecerebellum,only10–20%ofATPisrapidlyconverted
to adenosine. Furthermore biosensor measurements of
the breakdown of bath-applied ATP show that less than
10% of the applied ATP is converted to adenosine (Wall
MJ & Dale N, personal observations). For the complete
conversion of parallel ﬁbre ATP to occur, high densities of
ectonucleotidases would have to be localized at parallel
ﬁbre synapses around the site of release such that no
ATP escaped the conﬁnes of the synapse. Although
an ecto-ATPase (CD39) is present on the soma and
dendrites of Purkinje cells (Wang & Guidotti, 1998)
and 5 -nucleotidase activity is present on Bergmann glia
membranes (Schoen et al. 1987), the density of these
enzymes is unclear and this explanation seems to us
unlikely. A direct mechanism of adenosine release is
supported by Wong et al. (2006) who demonstrated that
trains of stimuli release adenosine at the calyx of Held
( d e t e c t e db yA 1 receptor mediated-inhibition of EPSCs)
with no detectable release of ATP (measured by means
of the luciferin–luciferase method). In the hippocampus,
the adenosine released by trains of stimuli (detected by
A1 receptor-mediated inhibition of EPSCs) could not be
reduced by blocking 5 -ectonucleotidases (Mitchell et al.
1993; Brager & Thompson, 2003). Frenguelli et al. (2007)
have also shown that adenosine release during ischaemia
does not arise from the extracellular metabolism of ATP.
The functional signiﬁcance
Irrespective of the detailed mechanism of adenosine
release, its dependency on parallel ﬁbre activity is
potentiallyverysigniﬁcant.Duringperiodsofhighparallel
ﬁbre activity adenosine will be released resulting in an
increased extracellular concentration of adenosine and
greater inhibition of parallel ﬁbre–Purkinje cell synapses.
Although the increased synaptic inhibition will reduce
the amplitude of EPSPs, the effects on high-frequency
synaptic transmission will probably be more important.
Duringhigh-frequencyparallelﬁbreactivitytheincreased
synaptic inhibition will reduce glutamate depletion and
thusmaintaintransmissiontoPurkinjecells(Kimuraetal.
2003;Wongetal.2006).ActivationofA1receptorsbyendo-
genous adenosine at the calyx of Held causes a reduction
in the relative amplitude of EPSCs at the end of the train
comparedwiththeEPSCsatthebeginning.Thisisbecause
there is no ambient level of adenosine at the calyx of
Held and adenosine is released and accumulates during
the stimulation, reaching a signiﬁcant concentration late
in the train. In contrast, Billups et al. (2005) have shown
that activation of presynaptic group III mGluRs has no
neteffectontheamplitudeofEPSCs.However,thereisan
increase in the size of the readily releasable vesicle pool
which is balanced by a reduction in the probability of
release.Thus,thesynapticstateofthesynapsehaschanged
andthemetabolicdemandhasbeenreduced.Wehavenot
measuredtheactionsofadenosineduringatrainofEPSPs
but have investigated recovery from depression following
atrain.WefoundthatblockingA1 receptorsgreatlyspeeds
the recovery of EPSP depression. Similar observations
have been observed following trains of stimuli at the
calyxofHeld,whereblockinggroupIIImGluRsincreased
the speed of recovery (Billups et al. 2005) while GABAB
receptor activation slowed recovery (Sakaba & Neher,
2003). The action of GABAB r e c e p t o r sa p p e a r st ob e
throughretardationofsynapticvesiclerecruitmentduring
sustained activity.
The dynamics of adenosine signalling are likely to be
complex as release of adenosine auto-inhibits its own
release. An intriguing question is whether adenosine
released from active parallel ﬁbres could laterally inhibit
neighbouring but inactive parallel ﬁbres. Interestingly
adenosine is also vaso-active and there is evidence that
periods of activity release adenosine resulting in the
dilatationofcerebellarbloodvessels(Li&Iadecola,1994).
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